We were therefore pleased to hear of a piece of research that forecasts major growth for the global track and trace solutions market. From being worth USD 2.93 billion in 2021, it is estimated to reach an expected value of USD 14.3 Billion by 2030, growing at a CAGR of 19.30% during the period from now until 2030.
As a business, of course, it excites us that the demand for the specialist services we offer is expected to grow at such a steep trajectory. We wouldn’t be in business if we didn’t want to grow – and the fact that there is such a strong, forecasted demand is of course good news to us.
The fact is that more and more governments across the world are understanding that consumers need the assurance that serialization technology can provide. They know they cannot gamble with the health of people – and cannot risk people being exposed to forged medicines which, at the very least will make them ill, or at the worst will kill them.
The problem continues to be vast.
When you look at the wider counterfeiting operation in the pharmaceutical sector, it is predicted that 10% of pharma products worldwide are counterfeit, with the global counterfeit drug market exceeding an eye-watering $75bn. Research further estimates that the death-toll caused as a result could increase to 10 million people by 2050.
Further estimates by the World Health Organization show that between 72 000 and 169 000 children may die from pneumonia every year after receiving counterfeit drugs, and that fake anti-malarial medication might be responsible for an additional 116 000 deaths
We should therefore all celebrate the forecasted high demands for the global track and trace solutions market.
Yes, it is good news for advanco.
But, on a much larger scale, it is good news for people right across the globe who will be under much less risk from taking dangerous, counterfeit medicines.
View the original article here.
Over the past few years, advanco has firmly established itself as a familiar face at the globe’s leading pharmaceutical networking events and conferences.
Global supply chains across multiple sectors produce large amounts of carbon, from CO2 created during manufacturing, through fossil fuels burned in transportation, to emissions from storage and distribution.
With Christmas now a distant memory, and with most of us starting our third full week back at our desks, it’s fair to say that it’s full steam ahead for another busy year in the world of pharmaceutical serialization.
Sign-up here to get the latest news, updates, insides and upcoming events delivered directly to your inbox.